1 deck published between 2019-04-30 and 2019-04-30 — 96 pages, 96 analysed slides total.
Each deck in chronological order — click to open. This is the story of the campaign as it unfolded.
PetIQ's grey-market vet-drug margins and rebate-dependent earnings are unsustainable as Merial goes direct-to-retail, while a $200M wellness-center cash burn and the CEO's Petters/Fleming ties imply 75-90% downside.